Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer

NDAQ:APHA - Post by User

Aphria Inc.

Bullboard Posts

Post by MoneyMaker90820on Oct 13, 2017 10:10am

136 Views

Post# 26809216

Ok news but long term looks better at 1 dollar all in FIRE

Just comparing all the big hitters here

Currently, Aphria is the benchmark for production costs as in Q1 of 2017, its all in costs per gram (g) dropped to $1.80, making it the best in the industry in Canada, compared to Canopy Growth Corp’s cost of $2.66 in Q1 2017, and Mettrum Inc.’s (CVE:MT) about $2.00/g. Supreme is estimating an initial cost of $2.50/g as it ramps up production but is aiming to be a $1/g producer by the time 2020 rolls around. As Supreme is a 100% greenhouse grower, just like Aphria, if management can continue to reduce and manage its costs as it has over the past year, once its sales license is received and commercial ramp-up achieved, you should see Supreme have a similar cost structure to Aphria.
https://smallcappower.com/expert-articles/supreme-pharmaceuticals-091116/

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario